Research ArticleArticle
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilova, Jacob A. Aelion, Sang-Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio and Shephard Mpofu
The Journal of Rheumatology March 2014, 41 (3) 414-421; DOI: https://doi.org/10.3899/jrheum.130637
Mark C. Genovese
From Stanford University, Palo Alto, California,
USA; Pôle de Recherche en Rhumatologie, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain and Cliniques Universitaires Saint-Luc, Brussels,
Belgium; Novartis Pharma AG, Basel,
Switzerland; NZOZ Centrum Medyczne Artur Racewicz, Bialystok,
Poland; Medical Plus, Uherske Hradiste,
Czech Republic; Arthritis Clinic, Jackson, Tennessee,
USA; Konkuk University Medical Center, Seoul,
South Korea; Health Research of Oklahoma, Oklahoma City, Oklahoma,
USA; Centre for Inflammatory Joint Diseases, Munich,
Germany; Kobe-Konan Yamate Clinic, Kobe,
Japan; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey,
USA.
Patrick Durez
Hanno B. Richards
Jerzy Supronik
Eva Dokoupilova
Jacob A. Aelion
Sang-Heon Lee
Christine E. Codding
Herbert Kellner
Takashi Ikawa
Sophie Hugot
Gregory Ligozio
REFERENCES
- 1.↵
- 2.↵
- 3.↵
- 4.↵
- Ziolkowska M,
- Koc A,
- Luszczykiewicz G,
- Ksiezopolska-Pietrzak K,
- Klimczak E,
- Chwalinska-Sadowska H,
- et al.
- 5.↵
- Honorati MC,
- Meliconi R,
- Pulsatelli L,
- Cane S,
- Frizziero L,
- Facchini A
- 6.↵
- 7.↵
- Shahrara S,
- Pickens SR,
- Dorfleutner A,
- Pope RM
- 8.↵
- 9.↵
- 10.↵
- 11.↵
- Hueber AJ,
- Asquith DL,
- Miller AM,
- Reilly J,
- Kerr S,
- Leipe J,
- et al.
- 12.↵
- 13.↵
- 14.↵
- 15.↵
- 16.↵
- Sebba A
- 17.↵
- Mertens M,
- Singh JA
- 18.↵
- 19.↵
- Hueber W,
- Patel DD,
- Dryja T,
- Wright AM,
- Koroleva I,
- Bruin G,
- et al.
- 20.↵
- 21.↵
- Lin AM,
- Rubin CJ,
- Khandpur R,
- Wang JY,
- Riblett M,
- Yalavarthi S,
- et al.
- 22.↵
- 23.↵
- Genovese MC,
- Durez P,
- Richards HB,
- Supronik J,
- Dokoupilova E,
- Mazurov V,
- et al.
- 24.↵
- 25.↵
- Emery P,
- Fleischmann R,
- Filipowicz-Sosnowska A,
- Schechtman J,
- Szczepanski L,
- Kavanaugh A,
- et al.
- 26.↵
- Pavelka K,
- Chon Y,
- Newmark R,
- Erondu N,
- Lin S
In this issue
The Journal of Rheumatology
Vol. 41, Issue 3
1 Mar 2014
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilova, Jacob A. Aelion, Sang-Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio, Shephard Mpofu
The Journal of Rheumatology Mar 2014, 41 (3) 414-421; DOI: 10.3899/jrheum.130637
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study
Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilova, Jacob A. Aelion, Sang-Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio, Shephard Mpofu
The Journal of Rheumatology Mar 2014, 41 (3) 414-421; DOI: 10.3899/jrheum.130637